Gainers
- Tenaya Therapeutics TNYA shares moved upwards by 11.4% to $2.72 during Wednesday's after-market session. The market value of their outstanding shares is at $112.5 million.
- NanoVibronix NAOV stock increased by 11.37% to $0.29. The market value of their outstanding shares is at $8.0 million.
- OpGen OPGN stock moved upwards by 10.23% to $0.21. The market value of their outstanding shares is at $11.2 million.
- Conformis CFMS shares increased by 8.25% to $2.23. The market value of their outstanding shares is at $16.7 million.
- VistaGen Therapeutics VTGN shares increased by 8.12% to $0.14. This security traded at a volume of 60.1K shares come close, making up 0.9% of its average volume over the last 100 days. The company's market cap stands at $28.8 million.
- WAVE Life Sciences WVE stock moved upwards by 6.17% to $4.47. The market value of their outstanding shares is at $388.4 million.
Losers
- Cosmos Holdings COSM stock decreased by 9.9% to $0.29 during Wednesday's after-market session. This security traded at a volume of 39.0 million shares come close, making up 190.5% of its average volume over the last 100 days. The company's market cap stands at $24.1 million.
- Pulse Biosciences PLSE shares fell 6.02% to $1.72. The company's market cap stands at $64.0 million.
- Venus Concept VERO shares fell 5.43% to $0.33. Venus Concept's trading volume hit 304.5K shares by close, accounting for 44.6% of its average volume over the last 100 days. The market value of their outstanding shares is at $22.3 million.
- MyMD Pharmaceuticals MYMD shares fell 4.61% to $2.07. The market value of their outstanding shares is at $81.7 million.
- BioVie BIVI shares fell 3.6% to $5.9. The company's market cap stands at $180.1 million.
- Syros Pharmaceuticals SYRS shares declined by 3.38% to $4.01. The market value of their outstanding shares is at $81.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in